Interactive alterations of arsenic and malathion in the disposition kinetics of pefloxacin

Archives of Environmental Contamination and Toxicology

Volumn 50, Issue 4, 2006, Pages 587-593

  Suresh Babu, N ^a,b   Malik, J K ^a   Rao, G S ^a   Aggarwal, Manoj ^a   Ranganathan, V ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER; MALATHION; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARSENIC; CATALYSIS; CYTOCHROME; DRINKING WATER; HEAVY METAL; MALATHION; PESTICIDE; PLASMA; TOXICOLOGICAL PHENOMENA;

ANIMAL EXPERIMENT; ANIMAL FOOD; AREA UNDER THE CURVE; ARTICLE; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; ENVIRONMENTAL EXPOSURE; FOOD INTAKE; MEAN RESIDENCE TIME; NONHUMAN; POLLUTION; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; ARSENIC; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; CHICKENS; DRUG INTERACTIONS; ENVIRONMENTAL POLLUTANTS; FLUOROQUINOLONES; MALATHION; MALE; TISSUE DISTRIBUTION;

ANIMALIA; AVES; GALLUS GALLUS;

EID: 33645577233     PISSN: 00904341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00244-005-1069-5     Document Type: Article

References (48)

1. Abdollahi M, Mostafalou S, Pournourmohammadi S, Shadnia S (2004) Oxidative stress and cholinesterase inhibition in saliva and plasma of rats following subchronic exposure to malathion. Comp Biochem Physiol C Toxicol Pharmacol 137:29-34
2. Adgate JL, Barr DB, Clayton CA, Eberly LE, Freeman NC, Lioy PJ, Needham LL, Pellizzari ED, Quackenboss JJ, Roy A, Sexton K (2001) Measurement of children's exposure to pesticides: analysis of urinary metabolite levels in a probability-based sample. Environ Health Perspect 109:583-590
3. Akhgari M, Abdollahi M, Kebryaeezadeh A, Hosseini R, Sabzevari O (2003) Biochemical evidence for free radical-induced lipid peroxidation as a mechanism for subchronic toxicity of malathion in blood and liver of rats. Hum Exp Toxicol 22:205-211
4. Albores A, Cebrian ME, Bach PH, Connelly JC, Hinton RH, Bridges JW (1989) Sodium arsenite induced alterations in bilirubin excretion and heme metabolism. J Biochem Toxicol 4:73-78
5. Albores A, Cebrian ME, Connelly JC, Bach PH, Bridges JW (1992) Effects of arsenite on hepatic mixed-function oxidase activity in rats. Xenobiotica 22:591-597
6. Aposhian HV (1997) Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Ann Rev Pharmacol Toxicol 37:397-419
7. ATSDR (2000) Toxicological Profile for Arsenic (update). Agency for Toxic Substances and Disease Registry. US Department of Health and Human Services, Atlanta, GA.
8. Beane Freeman LE, Dennis LK, Lynch CF, Thorne PS, Just CL (2004) Toenail arsenic content and cutaneous melanoma in Iowa. Am J Epidemiol 160:679-687
9. Brown SA (1996) Fluoroquinolones in animal health. J Vet Pharmacol Therap19:1-14
10. Chen CJ, Wang CJ (1990) Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 50:5470-5474
11. Danan G, Montay G, Cunci R, Erlinger S (1985) Pefloxacin kinetics in cirrhosis. Clin Pharmacol Ther 38:439-442
12. Davies BI, Maesen FP (1989) Drug interactions with quinolones. Rev Infect Dis Suppl 5:S1083-1090
13. Del Razo LM, Quintanilla-Vega B, Brambila-Colombres E, Calderon-Aranda ES, Manno M, Albores A (2001) Stress proteins induced by arsenic. Toxicol Appl Pharmacol 177:132-148
14. Eaton DL, Klaassen CD (2001) Principles of toxicology. In: Klaassen CD (ed) Casarett and Doull's toxicology: The basic science of poisons. McGraw-Hill, New York, pp 11-34
15. Falkner KC, McCallum GP, Cherian MG, Bend JR (1993) Effects of acute sodium arsenite administration on the pulmonary chemical metabolizing enzymes, cytochrome P-450 monooxygenase, NAD(P)H:quinone acceptor oxidoreductase and glutathione S-transferase in guinea pig: comparison with effects in liver and kidney. Chem-Biol Interact 86:51-68
16. Gelal A, Gumustekin M, Kalkan S, Guven H, Eminoglu O (2001) Effects of subchronic parathion exposure on cyclosporine pharmacokinetics in rats. J Toxicol Environ Health A 62:289-294
17. Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker Inc, New York
18. Groten JP, Cassee FR, Van Bladeren PJ, DeRosa C, Feron VJ (1999) Mixtures. In: Marguardt H, Schafer SG, McClellan R, Welsch F (eds) Toxicology. Academic Press, New York, pp 257-270
19. Hazarika A, Sarkar SN, Hajare S, Kataria M, Malik JK (2003) Influence of malathion pretreatment on the toxicity of anilofos in male rats: a biochemical interaction study. Toxicology 185:1-8
20. Institoris L, Siroki O, Undeger U, Basaran N, Desi I (2001) Immunotoxicological investigation of subacute combined exposure by permethrin and the heavy metals arsenic(III) and mercury(II) in rats. Int Immunopharmacol 1:925-933
21. Isea G, Martinez MA, Martinez Larranaga MR, Diaz MJ, Anadon A (2003) Pharmacokinetic characteristics of pefloxacin and its metabolite N-demethyl pefloxacin in chickens. J Vet Pharmacol Therap 26(Suppl 1):113-114
22. Jacobs J, Roussel R, Roberts M, Marek D, Wood S, Walton H, Dwyer B, Sinclair P, Sinclair J (1998) Effect of arsenite on induction of CYP1A and CYP2H in primary cultures of chick hepatocytes. Toxicol Appl Pharmacol 150:376-382
23. Khan AW, Ahmad SA (1997) Arsenic in drinking water: health effects and management. A Training Manual. Department of Occupational and Environmental Health, National Institute of Preventive and Social Medicine (NIPSOM), Dhaka, Bangladesh
24. Kutty RK, Daniel RF, Ryan DE, Levin W, Maines MD (1988) Rat liver cytochrome P-450b and P-420c are degraded to biliverdin by heme oxygenase. Arch Biochem Biophys 260:638-644
25. Lincoln BC, Aw TY, Bonkovsky HL (1989) Heme catabolism in cultured hepatocytes: evidence that heme oxygenase is the predominant pathway and that a proportion of synthesised heme is converted rapidly to biliverdin. Biochim Biophys Acta 992:49-58
26. Liu J, Kadiiska MB, Liu Y, Lu T, Qu W, Waalkes MP (2001) Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci 61:314-320
27. MacIntosh DL, Kabiru CW, Ryan PB (2001) Longitudinal investigation of dietary exposure to selected pesticides. Environ Health Perspect 109:145-150
28. Malik JK, Rao GS, Ramesh S, Muruganandan S, Tripathi HC, Shukla DC (2002) Pharmacokinetics of pefloxacin in goats after intravenous or oral administration. Vet Res Commun 26:141-149
29. Maroni M, Colosio C, Ferioli A, Fait A (2000) Organophosphorus pesticides. Toxicology 143:9-37
30. MEF (Ministry of Environment and Forest) (2004) Prevention and control of pollution. Annual Report 2003-2004, Government of India, New Delhi, pp 87-126 (Available at http://www.envfor.nic.in/report/0304/chap-05.pdf)
31. Montay G, Goueffon Y, Roquet F (1984) Absorption, distribution, metabolic fate and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys and humans. Antimicrob Agents Chemother 25:463-472
32. Montay G, Tassel JP (1985) Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue. J Chromatogr 339:214-218
33. Nielsen P, Gyrd-Hansen N (1997) Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Pharmacol Toxicol 80:246-250
34. Petri WA, Jr (2001) Antimicrobial agents (continued): sulfonamides, trimethoprim-sulfamethoxazole, quinolones and agents for urinary tract infections. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman and Gilman's the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 1179-1188
35. Puntarulo S, Cederbaum AI (1988) Effect of oxygen concentration on microsomal oxidation of ethanol and generation of oxygen radicals. Biochem J 251:787-794
36. Ramanathan K, Shila S, Kumaran S, Panneerselvam C (2003) Protective role of ascorbic acid and alpha-tocopherol on arsenic-induced microsomal dysfunctions. Hum Exp Toxicol 22:129-136
37. Sakurai T, Kojima C, Ochiai M, Ohta T, Fujiwara K (2004) Evaluation of in vivo acute immunotoxicity of a major organic arsenic compound arsenobetaine in seafood. Int Immunopharmacol 4:179-184
38. Sanyal PK (1997) Disposition kinetics of albendazole in buffalo and cattle. J Vet Pharmacol Therap 20:240-242
39. Sardana MK, Drummond GS, Sassa S, Kappas A (1981) The potent heme oxygenase inducing action of arsenic and parasiticidal arsenicals. Pharmacology 23:247-253
40. Savabieasfahani M, Lochmiller RL, Rafferty DP, Sinclair JA (1998) Sensitivity of wild cotton rats (Sigmodon hispidus) to the immunotoxic effects of low-level arsenic exposure. Arch Environ Contam Toxicol 34:289-296
41. Savage EP, Keefe TJ, Wheeler HW, Mounce L, Helwic L, Applehams F, Goes E, Goes T, Mihlan G, Rench J, Taylor DK (1981) Household pesticide usage in the United States. Arch Environ Health 36:304-309
42. Siller FR, Quintanilla-Vega B, Cebrian ME, Albores A (1997) Effects of arsenite pretreatment on the acute toxicity of parathion. Toxicology 116:59-65
43. Simmons JE (1995) Chemical mixtures: challenge for toxicology and risk assessment. Toxicology 105:111-119
44. Snedecor GW, Cochran WG (1989) Statistical methods. Oxford and IBH Publishing Company, New Delhi
45. Srikanth NS, Seth PK (1990) Alterations in xenobiotic metabolizing enzymes in brain and liver of rats coexposed to endosulfan and malathion. J Appl Toxicol 10:157-160
46. Storm JE, Rozman KK, Doull J (2000) Occupational exposure limits for 30 organophosphate pesticides based on inhibition of red blood cell acetylcholinesterase. Toxicology 150:1-29
47. Varshneya C, Bahga HS, Sharma LD (1986) Effect of dietary malathion on hepatic microsomal drug-metabolizing systems of Gallus domesticus. Toxicol Lett 31:107-111
48. Wilkinson GR (2001) Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Hardman JG. Limbird LE, Gilman AG (eds) Goodman and Gilman's the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 3-29